Skip to main content

Month: January 2024

CrossFirst Bankshares, Inc. Reports Fourth Quarter and Record Full-Year 2023 Results

LEAWOOD, Kan., Jan. 22, 2024 (GLOBE NEWSWIRE) — CrossFirst Bankshares, Inc. (Nasdaq: CFB), the bank holding company for CrossFirst Bank, today reported operating results for the fourth quarter and full-year ended December 31, 2023. The fourth quarter and full-year earnings release can be viewed here: https://investors.crossfirstbankshares.com/financials/quarterly-reports CrossFirst Bankshares, Inc. will host a conference call to review fourth quarter and full-year results on Tuesday, January 23, 2024, at 10 a.m. CT / 11 a.m. ET. To access the event by telephone, please dial (844) 481-2831 at least fifteen minutes prior to the start of the call and request access to the CrossFirst Bankshares call. International callers should dial +1 (412) 317-1851 and request access as directed above. The event will also be broadcast live over...

Continue reading

Verizon wins J.D. Power award for Wireless Network Quality 32nd time in a row

Verizon is the most awarded for Network Quality, according to J.D. Power – 32 times in a row; more than any other wireless provider. Verizon continues to rank first, significantly above the industry average in the Northeast, Southeast, and Southwest regions, with fewest call, messaging and data problems reported. Verizon received J.D. Power awards in all six regions — achieving top score across all problem areas.**NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) — Verizon prides itself on delivering the most reliable, highest performing and most secure network, and for the 32nd consecutive time, customers agree that Verizon is unmatched in wireless network quality. The latest J.D. Power 2024 U.S. Wireless Network Quality Performance Study – Volume 1, names Verizon as the most awarded brand for Wireless Network Quality. Verizon...

Continue reading

Prime Drink Group Corp. Enters Into Binding Letter of Intent To Acquire Triani Canada Inc.

Triani is a Québec-based company specialized in the production, bottling and sale of alcoholic and non-alcoholic beverages with unaudited non-IFRS annual net revenue of $28.4 million and Adjusted EBITDA of $4.4 million for the year ended November 30, 2023. Triani also owns a 100,000 ft2 beverage processing plant, as well as the Glutenberg, Oshlag, Vox Populi and 2 Frères beer brands, and the Baron, Octane and Mojo beverage brands.MONTREAL, Jan. 22, 2024 (GLOBE NEWSWIRE) — Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company”) announces that it has entered into a binding letter of intent dated January 21, 2024 (the “Letter of Intent”) with 9296-0186 Québec Inc. (“9296”) whereby the Company will acquire all of the issued and outstanding common shares of Triani Canada Inc. (“Triani”, and together with 9296, the “Vendor”)...

Continue reading

SmartCentres Real Estate Investment Trust to Release 2023 Fourth Quarter and Year-End Results and Host Conference Call

TORONTO, Jan. 22, 2024 (GLOBE NEWSWIRE) — SmartCentres Real Estate Investment Trust (“SmartCentres”) (TSX: SRU.UN) announced today that it will be reporting its financial results for the three months and year ended December 31, 2023 after the market closes on Wednesday, February 14, 2024. Management will hold a conference call on Thursday, February 15, 2024 at 3:00 p.m. (ET). Interested parties are invited to access the call by dialing 1-855-353-9183 and then keying in the participant passcode 97190#. A recording of this call will be made available Thursday, February 15, 2024, through to Thursday, February 22, 2024. To access the recording, please call 1-855-201-2300, enter the conference access code 97190# and then key in the playback access code 0114192#. Recordings of SmartCentres’ current and previous conference calls can be...

Continue reading

Chocolate Market Size Worth USD 161.99 Billion in 2032 | Emergen Research

Increasing demand for premium chocolates, growing awareness of the advantages of dark chocolate, and rising innovations in new chocolate products are some of the key factors driving Chocolate market revenue growth. Vancouver, Jan. 22, 2024 (GLOBE NEWSWIRE) — The global chocolate market size was USD 115.80 billion in 2022 and is expected to register a revenue CAGR of 3.4% during the forecast period. Increasing demand for premium chocolates, growing awareness of the advantages of dark chocolate, and rising innovations in new chocolate products are some of the key factors driving market revenue growth. Growing awareness of the advantages of dark chocolate is also a major factor driving market revenue growth. Nutrient-rich dark chocolate has a good impact on human health. Consuming dark chocolate with a high cocoa content in moderation...

Continue reading

Freddie Mac Multifamily Supports Over 423,000 Affordable Rental Units in 2023, on Track to Exceed Affordable Housing Goals

MCLEAN, Va., Jan. 22, 2024 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) Multifamily today announced its 2023 volume totaled over $49 billion, including $48.3 billion in multifamily financing and over $883 million in Low-Income Housing Tax Credit (LIHTC) equity investments. The company met its mission-driven affordable housing targets, supporting 423,177 affordable rental units across the United States. The Freddie Mac data released today indicates that the company will achieve all of its 2023 Multifamily affordable housing goals set by the Federal Housing Finance Agency (FHFA). A total of 66% of 2023 production volume qualified as “mission-driven affordable housing,” far exceeding the 50% goal set by FHFA. More than 67% of goal-eligible units financed through loan acquisitions were affordable to low-income residents earning less...

Continue reading

Heart Failure Drugs Market Size Worth USD 21.63 Billion in 2032 | Emergen Research

Increasing prevalence of heart failure, rising numbers of elderly individuals, increasing number of drugs in pipeline in developmental stages, and increase in risk factors associated with lifestyle choices are some of the key factors driving Heart Failure Drugs market revenue growth. Vancouver, Jan. 22, 2024 (GLOBE NEWSWIRE) — The global heart failure drugs market size was USD 12.20 Billion in 2022 and is expected to register a revenue CAGR of 5.9% during the forecast period. Increasing prevalence of heart failure, rising numbers of elderly individuals, increasing number of drugs in pipeline in developmental stages, and increase in risk factors associated with lifestyle choices are some of the key factors driving market revenue growth. Rising number of elderly individuals is also a key factor driving market revenue growth. When...

Continue reading

Invisible Orthodontics Market Size Worth USD 15.34 Billion in 2032 | Emergen Research

Increasing number of orthodontic issues, steady development of orthodontic technologies, and increasing awareness of the consequences of untreated dental misalignments are some of the key factors driving Invisible Orthodontics market revenue growth Vancouver, Jan. 22, 2024 (GLOBE NEWSWIRE) — The global invisible orthodontics market size was USD 4.14 Billion in 2022 and is expected to register a revenue CAGR of 14.0% during the forecast period. Increasing number of orthodontic issues, steady development of orthodontic technologies, the global proliferation of dental clinics and hospitals, and increasing awareness of the consequences of untreated dental misalignments are some of the key factors driving market revenue growth. Steady and continuous development of orthodontic technologies is a key factor driving market revenue growth....

Continue reading

Coronary Stents Products Market Size Worth USD 22.78 Billion in 2032 | Emergen Research

The steady market revenue growth can be attributed to increasing prevalence of cardiac disorders such as coronary artery disease (CAD) & heart failure, rising investments & funding toward production of such devices, and rapid advancements in angioplasty techniques. Vancouver, Jan. 22, 2024 (GLOBE NEWSWIRE) — The global coronary stents products market size was USD 11.09 Billion in 2022 and is expected to register a revenue CAGR of 7.5% during the forecast period. The steady market revenue growth can be attributed to increasing prevalence of cardiac disorders such as coronary artery disease (CAD) & heart failure, rising investments & funding toward production of such devices, and rapid advancements in angioplasty techniques. One of the major factors driving revenue growth of the market is increasing prevalence...

Continue reading

Kering: Monthly statement on the total number of shares and voting rights (January 2024)

Kering – Statement Number of Shares and voting rights – 15.01.2024 KeringSociété anonyme with a share capital of €493,683,112Head office: 40, rue de Sèvres – 75007 PARIS552 075 020 RCS PARIS    January 22, 2024   Monthly statementon the total number of shares and voting rights(articles L.233-8 of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (AMF – Autorité des Marchés Financiers)Date     Total number ofshares   Total number of voting rightstheoretical 1 exercisable 2January 15, 2024 123,420,778 176,571,933 175,730,0611 Calculated based on all shares with voting rights, including treasury shares stripped of voting rights (Art. 223-11 of AMF General Regulation). 2 Excluding treasury shares stripped of voting rights.AttachmentKering –...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.